Arcus Biosciences
Price & Volume
Stats
See moreOpen | $10.02 |
Previous Close | $10.06 |
Day Range | $9.75-$10.02 |
52W Range | $6.50-$18.98 |
Market Cap | $1B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $262M |
Revenue Growth (YoY) | 310.3% |
Gross Profit (12 Mos) | -$223M |
Diluted EPS | -$3.14 |
News
See moreYahoo Finance • 6 days ago
Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears
Yahoo Finance • 8 days ago
Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
Yahoo Finance • 17 days ago
Arcus Biosciences' SWOT analysis: HIF-2alpha program drives stock outlook
Yahoo Finance • last month
Arcus' pancreatic cancer drug quemliclustat receives FDA orphan status
About
CEO | Dr. Terry J. Rosen Ph.D. |
CFO | Mr. Robert C. Goeltz II |
Address | 3928 Point Eden Way, Hayward, CA, United States, 94545 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 627 |
